Sistema de Información Esencial en Terapéutica y Salud

@SIETES7

Última actualización: 30/3/2020
SIETES contiene 92954 citas

 
 
<< anterior 21 a 40 de 99 siguiente >>
Presentar resultados
Seleccionar todas
21. Cita con resumen
Morrison RH, Hall NS, Said M, Rice T, Groff H, Brodine SK, Slymen D, Lederman ER. Risk factors associated with complications and mortality in patients with Clostridium difficile infection. Clin Infect Dis 2011;53:1173-8. [Ref.ID 91843]
22. Cita con resumen
Anónimo. Fidaxomicin (Dificid) for Clostridium difficile infection. Med Lett Drugs Ther 2011;53:73-4. [Ref.ID 91500]
23. Cita con resumen
Rothberg MB, Pekow PS, Lahti M, Brody O, Skiest DJ, Lindenauer PK. Antibiotic therapy and treatment failure in patients hospitalized for acute exacerbations of chronic obstructive pulmonary disease. JAMA 2010;303:2035-42. [Ref.ID 88508]
24. Cita con resumen
Voelker R. Increased Clostridium difficile virulence demands new treatment approach. JAMA 2010;303:2017-9. [Ref.ID 88506]
25. Cita con resumen
Howell D, Novack V, Grgurich P, Soulliard D, Novack L, Pencina M, Talmor D. Iatrogenic gastric acid suppression and the risk of nosocomial Clostridium difficile infection. Arch Intern Med 2010;170:784-90. [Ref.ID 88368]
26.Enlace a cita original
Peyrière H, Roux C, Ferard C, Deleau N, Kreft-Jais C, Hillaire-Buys D, Boulenger J-P, Blayac J-P, The French Network of the Pharmacovigilance Centers. Antipsychotics-induced ischaemic colitis and gastrointestinal necrosis: a review of the French pharmacovigilance database. Pharmacoepidemiol Drug Saf 2009;18:948-55. [Ref.ID 86840]
27. Cita con resumen
Anónimo. Neuroleptiques: entérocolites nécrosantes. Prescrire 2008;28:751. [Ref.ID 84257]
28. Cita con resumen
Anónimo. C difficile deaths are no the rise in England and Wales. BMJ 2008;337:534. [Ref.ID 84019]
29.
Murphy MS. Management of bloody diarrhoea in children in primary care. BMJ 2008;336:1010-5. [Ref.ID 82888]
30.
Anónimo. Isotrétinoïne et lésions intestinales. Prescrire 2008;28:271-3. [Ref.ID 82551]
32.
Anónimo. Infliximab. Rectocolite hémorragique: attention aux risques à long terme. Prescrire 2007;27:253-4. [Ref.ID 79726]
33.
Collins P, Rhoddes J. Ulcerative colitis: diagnosis and management. BMJ 2006;333:340-3. [Ref.ID 77846]
34. Cita con resumen
Anónimo. Glucosamine products. 86 reports to date in Sweden. Sweden. WHO Pharmaceuticals Newsletter 2006;3:3. [Ref.ID 77498]
35.Tiene citas relacionadas
Gerding DN. Metronidazole for Clostridium difficile-associated disease: its okay for mon?. Clin Infect Dis 2005;40:103. [Ref.ID 76925]
36.Tiene citas relacionadas
Pépin J, et al.. Increasing risk of relapse after treatment of Clostridum difficile colitis in Quebec, Canada. Clin Infect Dis 2005;40:1591-7. [Ref.ID 76924]
37.Tiene citas relacionadas
Musher DM, et al.. Relatively poor outcome after treatment of Clostridium difficile colitis with metronidazole. Clin Infect Dis 2005;40:1586-90. [Ref.ID 76923]
38.
Anónimo. Effets indésirables digestifs des ains: au-delà du duodénum aussi. Prescrire 2005;25 (267):830-4. [Ref.ID 75605]
39.Tiene citas relacionadas Cita con resumen
Warny M, Pepin J, Fang A, Killgore GE, Thompson A, Brazier J, Frost E, McDonald LC. Toxin production by an emerging strain of Clostridium difficile associated with outbreaks of severe disease in North America and Europe. Lancet 2005;366:1079-84. [Ref.ID 74971]
40.Tiene citas relacionadas Cita con resumen
Norén T. Outbreak from a high-toxin intruder: Clostridium difficile. Lancet 2005;366:1053-4. [Ref.ID 74961]
Seleccionar todas
 
<< anterior 21 a 40 de 99 siguiente >>